C12N 2840/102
Inhibiting translation
Official title: inhibiting translation
C12N2840/102 (Inhibiting translation) appears on 48 US grants and 85 published applications in this corpus.
Search patents in C12N- Granted patents
- 48
- Published applications
- 85
- Assignees
- 51
- Inventors
- 127
- Latest grant
- 17 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 1 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 3 |
| 2010 | 1 | 4 |
| 2011 | 3 | 7 |
| 2012 | 0 | 2 |
| 2013 | 3 | 8 |
| 2014 | 3 | 8 |
| 2015 | 8 | 6 |
| 2016 | 6 | 7 |
| 2017 | 5 | 6 |
| 2018 | 5 | 3 |
| 2019 | 3 | 7 |
| 2020 | 1 | 2 |
| 2021 | 4 | 6 |
| 2022 | 2 | 2 |
| 2023 | 1 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 3 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- GM3 synthase vectors and uses thereof17 Feb 2026US 12,553,036 B2The Clinic for Special Children, Inc.
- Viral vector production system6 Aug 2024US 12,054,735 B2Oxford Biomedica (UK) Limited
- Isolation of novel AAV's and uses thereof28 Nov 2023US 11,826,434 B2University of Massachusetts
- RNA-based logic circuits with RNA binding proteins, aptamers and small molecules7 Jun 2022US 11,351,271 B2Kyoto University
- Methods and compositions for use of non-coding RNA in cell culturing and selection22 Feb 2022US 11,254,935 B2HocusLocus, LLC
- Viral vector carrying smn gene expression cassette and use thereof13 Aug 2026US 2026/0234668 A1Genecombio Ltd.
- Gm3 synthase vectors and uses thereof23 Jul 2026US 2026/0209721 A1The Clinic for Special Children, Inc.
- Yeast with enhanced astaxanthin25 Sep 2025US 2025/0297208 A1Bioproton Pty Ltd
- Gene therapy for treatment of mucopolysaccharidosis iiia6 Feb 2025US 2025/0041445 A1Amicus Therapeutics, Inc.
- Adeno-Associated-Virus Rep Sequences, Vectors and Viruses23 Jan 2025US 2025/0027056 A1The Research Foundation for The State University of New York
Most cited
By later US patents
- Genetic constructs for delaying or repressing the expression of a target gene369US 6,573,099 B2Benitec Australia Limited · 2003
- Isolation of novel AAV'S and uses thereof107US 9,217,155 B2University of Massachusetts · 2015
- Isolation of novel AAV's and uses thereof63US 9,596,835 B2University of Massachusetts · 2017
- MiRNA-regulated differentiation-dependent self-deleting cassette32US 8,697,851 B2Regeneron Pharmaceuticals, Inc. · 2014
- Isolation of novel AAV's and uses thereof28US 10,300,146 B2University of Massachusetts · 2019